EUVIMEDEUVIMED entdecken
Crossref

Monoclonal gammopathy of undetermined significance and the risk of thrombotic events: Results from iStopMM, a prospective population‐based screening study

Sæmundur Rögnvaldsson iD, Alessandro Gasparini, Sigrun Thorsteinsdottir, Ingigerdur Sverrisdottir iD, Elias Eythorsson, Thorir Einarsson Long, Robert Palmason, Brynjar Vidarsson, Pall Torfi Onundarson, Bjarni A Agnarsson, Margret Sigurdardottir, Isleifur Olafsson und 12 weitere

British Journal of Haematology · 2025

DOI: 10.1111/bjh.19957 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Sæmundur Rögnvaldsson und 23 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Iceland, Reykjavík, Iceland. Hauptthemen laut MEDLINE: Monoclonal Gammopathy of Undetermined Significance, Thrombosis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Landspítali Háskólasjúkrahús, International Myeloma Foundation, Horizon 2020 Framework Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monoclonal gammopathy of undetermined significance (MGUS) is the asymptomatic precursor of multiple myeloma and related diseases but has also been associated with thrombosis. Prior studies have not been based on screened cohorts leading to bias. We assessed the risk of thrombosis in a cohort of 75 422 individuals over 40 years old who were screened for MGUS in Iceland. We also evaluated the association of M protein concentration with thrombotic risk. A total of 3668 participants had MGUS. After a median follow‐up of ~3.7 years, 124 venous and 252 arterial thrombotic events (10.3 and 21.0 per 1000 person years respectively) were observed in the MGUS group, compared to 1509 and 3471 in the non‐MGUS group (6.0 and 13.8 per 1000 person years respectively). After adjusting for multiple confounders, MGUS was associated with an increased risk of venous thrombosis (hazard ratio [HR] = 1.43; 95% confidence interval [CI]: 1.19–1.73) but not arterial thrombosis (HR = 0.96; 95% CI: 0.87–1.13). M protein concentration was not associated with venous ( p = 0.72) or arterial ( p = 0.95) thrombosis. The findings show, in a screened cohort, that MGUS is associated with venous, but not arterial, thrombosis. Furthermore, they suggest that there is a subset of individuals with MGUS with subclinical monoclonal gammopathy of thrombotic significance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Monoclonal Gammopathy of Undetermined SignificanceThrombosisHumansMaleFemaleMiddle AgedAgedProspective StudiesIcelandAdultRisk FactorsFollow-Up Studies

Stichwörter der Autor:innen

epidemiologymonoclonal gammopathy of undetermined significancerisk factorsthrombosisvenous thrombosis

Autor:innen und Institutionen

  • Faculty of Medicine, University of Iceland, Reykjavík, Iceland.
  • Landspítali University Hospital, Reykjavík, Iceland.
  • Red Door Analytics, Stockholm, Sweden.
  • Rigshospitalet, Copenhagen, Denmark.
  • Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Skåne University Hospital, Lund, Sweden.

ORCID-Profile: Sæmundur Rögnvaldsson, Ingigerdur Sverrisdottir, Ola Landgren, Sigurdur Yngvi Kristinsson

Förderung

  • Landspítali Háskólasjúkrahús
  • International Myeloma Foundation
  • Horizon 2020 Framework Programme
  • The Icelandic Research Fund
  • Sylvester Comprehensive Cancer Center NCI Core Grant
  • Riney Family Multiple Myeloma Research Program Fund
  • Tow Foundation
  • Myeloma Solutions Fund

Zitieren

APA

Rögnvaldsson, S., Gasparini, A., Thorsteinsdottir, S., Sverrisdottir, I., Eythorsson, E., Long, T. E., Palmason, R., Vidarsson, B., Onundarson, P. T., Agnarsson, B. A., Sigurdardottir, M., Olafsson, I., Thorsteinsdottir, I., Oskarsson, J. T., Jonsson, A., Palsson, R., Indriðason, O. S., Olafsson, A., Hultcrantz, M., …, & Kristinsson, S. Y. (2025). Monoclonal gammopathy of undetermined significance and the risk of thrombotic events: Results from iStopMM, a prospective population‐based screening study. British Journal of Haematology. https://doi.org/10.1111/bjh.19957

Vancouver

Rögnvaldsson S, Gasparini A, Thorsteinsdottir S, Sverrisdottir I, Eythorsson E, Long TE, et al. Monoclonal gammopathy of undetermined significance and the risk of thrombotic events: Results from iStopMM, a prospective population‐based screening study. British Journal of Haematology. 2025. doi:10.1111/bjh.19957

BibTeX
@article{Rgnvaldsson2025,
  author = {Rögnvaldsson, Sæmundur and Gasparini, Alessandro and Thorsteinsdottir, Sigrun and Sverrisdottir, Ingigerdur and Eythorsson, Elias and Long, Thorir Einarsson and Palmason, Robert and Vidarsson, Brynjar and Onundarson, Pall Torfi and Agnarsson, Bjarni A and Sigurdardottir, Margret and Olafsson, Isleifur and Thorsteinsdottir, Ingunn and Oskarsson, Jon Thorir and Jonsson, Asbjorn and Palsson, Runolfur and Indriðason, Olafur Skuli and Olafsson, Andri and Hultcrantz, Malin and Durie, Brian G M and Harding, Stephen and Landgren, Ola and Love, Thorvardur Jon and Kristinsson, Sigurdur Yngvi},
  title = {Monoclonal gammopathy of undetermined significance and the risk of thrombotic events: Results from iStopMM, a prospective population‐based screening study},
  journal = {British Journal of Haematology},
  year = {2025},
  doi = {10.1111/bjh.19957}
}
Kostenlos starten →